Preclinical Research

(Image: Getty/masterzphotois)

How to reduce the odds of failure in late phase clinical trials

By Melissa Fassbender

Improving the prognostic value of early phase data is among one of several ways to increase the probability of successes in drug development, a process which has become more expensive as failure rates have risen, says an industry expert.

People on the Move: Outsourcing-Pharma roundup June ‘19

People on the Move: Outsourcing-Pharma roundup June ‘19

By Melissa Fassbender

Newly-minted Signant Health named a new CTO, Parexel bolstered its Japan presence, and BioAgilytix’s CEO was appointed to the board of FSD Pharma – a company developing products based on cannabinoids – among other people on the move in June.

Follow us

Products

View more

Webinars